Human papillomavirus vaccine series follow-through: comparison of four clinics in an academic medical center.
adolescent health
public health
vaccine uptake
Journal
International journal of adolescent medicine and health
ISSN: 2191-0278
Titre abrégé: Int J Adolesc Med Health
Pays: Germany
ID NLM: 8506960
Informations de publication
Date de publication:
01 Dec 2022
01 Dec 2022
Historique:
received:
15
06
2020
accepted:
04
08
2020
pubmed:
2
9
2020
medline:
2
9
2020
entrez:
2
9
2020
Statut:
epublish
Résumé
The Centers for Disease Control & Prevention (CDC) recommends that the human papillomavirus (HPV) vaccine series be initiated at ages 11-12 years, but many children never follow-through with the series. By examining differences in clinic-specific vaccine series follow-through rates across four clinics, we aimed to identify best practices related to communication around the vaccine and pathways to follow-through. We used the electronic medical record (EMR) to retrospectively analyze HPV vaccine follow-through at four clinic settings. We limited the sample to children ages 11-17 who received a dose of the vaccine series at any of the clinics between January 2015 and June 2018. The primary outcome was follow-through of the HPV vaccine series within 18 months of initiation. A total of 3,813 patients were included in this study, 29% of which followed through with the HPV vaccine series. There was significant variability of vaccine follow-through among the clinics (p<0.001), with the Med/Peds clinic having the highest rate of follow-through (32%). After adjusting for confounding variables, multivariable analysis found that Med/Peds and Family Medicine had higher odds of HPV vaccine series follow-through than the Pediatrics clinic. We found that the likelihood of vaccine series follow-through was highest when the series was started in the Med/Peds and Family Medicine clinics, compared to Pediatrics and Adolescent Medicine. These results suggest that further qualitative research is needed to understand what communication strategies are most effective at facilitating HPV vaccine uptake among adolescents, and how the most effective strategies can be shared among clinics.
Identifiants
pubmed: 32870809
doi: 10.1515/ijamh-2020-0145
pii: /j/ijamh.ahead-of-print/ijamh-2020-0145/ijamh-2020-0145.xml
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
431-436Informations de copyright
© 2020 Walter de Gruyter GmbH, Berlin/Boston.
Références
American Academy of Pediatrics. HPV vaccine implementation guidance; 2017. PDF.
Centers for Disease Control and Prevention. Morbidity and mortality weekly report; 2015, vol. 64.
Meites, E, Szilagyi, PG, Chesson, HW, Unger, ER, Romero, JR, Markowitz, LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2019;68:698–702.
Walker, TY, Elam-Evans, LD, Yankey, D, Markowitz, LE, Williams, CL, Fredua, B, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2018. MMWR Morb Mortal Wkly Rep 2019;68:718–23. https://doi.org/10.15585/mmwr.mm6733a1externalicon.
Richards, M, Peters, M, Sheeder, J. Human papillomavirus vaccine: continuation, completion, and missed opportunities. J Pediatr Adolesc Gynecol 2016;29:117–21. https://doi.org/10.1016/j.jpag.2015.08.003.
Inguva, S, Barnard, M, Ward, L, Yang, Y, Pittman, E, Banahan, BFIII, et al.Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid. Vaccine 2019;38:2051–7. https://doi.org/10.1016/j.vaccine.2019.12.030.
Sauver, JSt, Finney Rutten, L, Ebbert, J, Jacobson, DJ, McGree, ME, Jacobson, RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med 2016;89:327–33. https://doi.org/10.1016/j.ypmed.2016.02.039.
Spencer, J, Calo, W, Brewer, N. Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis. Prev Med 2019;123:197–203. https://doi.org/10.1016/j.ypmed.2019.03.037.
Tan, W, Viera, AJ, Rowe-West, B, Grimshaw, A, Quinn, B, Walter, EB. The HPV vaccine: are dosing recommendations being followed? Vaccine 2011;29:2548–54. https://doi.org/10.1016/j.vaccine.2011.01.066.
Chou, B, Krill, L, Horton, B, Barat, C, Trimble, C. Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstet Gynecol 2011;118:14–20. https://doi.org/10.1097/AOG.0b013e318220ebf3.
Abdullahi, LH, Kagina, BM, Ndze, NV, Hussey, GD, Wiysonge, CS. Improving vaccination uptake among adolescents. Cochrane Database Syst Rev 2020. https://doi.org/10.1002/14651858.cd011895.pub2.
Berenson, A, Rupp, R, Dinehart, E, Cofie, L, Kuo, Y, Hirth, J. Achieving high HPV vaccine completion rates in a pediatric clinic population. Hum Vaccin Immunother 2019;15:1562–9. https://doi.org/10.1080/21645515.2018.1533778.
Holman, DM, Benard, V, Roland, KB, Watson, M, Liddon, N, Stokley, S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014;168:76–82. https://doi.org/10.1001/jamapediatrics.2013.2752.
Dempsey, AF, Pyrznawoski, J, Lockhart, S, Barnard, J, Campagna, EJ, Garrett, K, et al. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr 2018;172;e180016. https://doi.org/10.1001/jamapediatrics.2018.0016.
Gilkey, M, Calo, W, Moss, J, Shah, PD, Marciniak, MW, Brewer, NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine 2016;34:1187–92. https://doi.org/10.1016/j.vaccine.2016.01.023.
Dilley, S, Peral, S, Straughn, MJr., Scarinci, I. The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med 2018;113:124–31. https://doi.org/10.1016/j.ypmed.2018.05.021.
Perkins, R, Zisblatt, L, Legler, A, Trucks, E, Hanchate, A, Gorin, SS. Effectiveness of a provider-focused intervention to improved HPV vaccination rates in boys and girls. Vaccine 2015;33:1223–9. https://doi.org/10.1016/j.vaccine.2014.11.021.